Search and analyze individual stocks with comprehensive metrics

Walpar Nutrition

WALPARPharmaceuticals & Biotechnology

Fundamental Score

...

Walpar Nutrition Share Price & Market Analysis

Current Market Price (CMP)
115.10
No change data available
Market Cap
37.51 (Cr)
Industry
Pharmaceuticals & Biotechnology

Profitability Metrics

Average

Return on Equity

15.09%
Average

Return on Capital Employed

16.08%
Poor

Operating Profit Margin (5Y)

7.63%
Poor

Dividend Yield

0.00%

Valuation Metrics

Excellent

Price to Earnings

16.17x

Market Capitalization

37.51 (Cr)

Industry P/E

33.97x

Growth Metrics

Poor

YoY Quarterly Profit Growth

-11.86%
Excellent

YoY Quarterly Sales Growth

25.05%

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Financial Health

Average

Debt to Equity

0.47x
Excellent

Interest Coverage

14.38x
Poor

Free Cash Flow (5Y)

-5.97 (Cr)

Ownership Structure

Good

Promoter Holding

68.52%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
68.52%
Promoter Holding
37.51 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of WALPAR across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Strong Return on Equity (15.09%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (16.08%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Attractive Valuation (P/E: 16.17 vs Industry: 33.97)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Strong Revenue Growth (25.05%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Strong Interest Coverage (14.38x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Balanced Promoter Holding (68.52%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

4 factors identified

Profit Decline Concern (-11.86%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.

Negative Free Cash Flow (₹-5.97 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

📊 Educational Market Overview

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.

Loading Peer Comparison

Finding companies in the Pharmaceuticals sector...

Financial Statements

Comprehensive financial data for Walpar Nutrition

About WALPAR

Company Details

Symbol:WALPAR
Industry:Pharmaceuticals & Biotechnology
Sector:Pharmaceuticals

Market Information

Market Cap:37.51 (Cr)
P/E Ratio:16.17
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:0.00%

WALPAR Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)15.09%
Return on Capital Employed16.08%
Operating Profit Margin (5Y)7.63%
Debt to Equity Ratio0.47
Interest Coverage Ratio14.38

Growth & Valuation

Sales Growth (5Y)N/A%
Profit Growth (5Y)N/A%
EPS Growth (5Y)N/A%
YoY Quarterly Profit Growth-11.86%
YoY Quarterly Sales Growth25.05%

Frequently Asked Questions

What is the current price of WALPAR?

WALPAR is currently trading at ₹115.10 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of WALPAR shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of WALPAR and what does it mean?

WALPAR has a P/E ratio of 16.17x compared to the industry average of 33.97x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹16 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.

How is WALPAR performing according to Bull Run's analysis?

WALPAR has a Bull Run fundamental score of 38.4/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 15.09%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does WALPAR belong to?

WALPAR operates in the Pharmaceuticals & Biotechnology industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Walpar Nutrition. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for WALPAR?

WALPAR has an ROE of 15.09%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Walpar Nutrition generates profits from shareholders' equity. An ROE of 15% means the company generates ₹15 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is WALPAR's debt-to-equity ratio and what does it indicate?

WALPAR has a debt-to-equity ratio of 0.47, which indicates moderate leverage that should be monitored. This means the company has ₹47 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.

What is WALPAR's dividend yield and is it a good dividend stock?

WALPAR offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has WALPAR grown over the past 5 years?

WALPAR has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in WALPAR and why does it matter?

Promoters hold 68.52% of WALPAR shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.08%.

How does WALPAR compare with its industry peers?

WALPAR trades at P/E 16.17x vs industry average 33.97x, with ROE of 15.09% and ROCE of 16.08%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether WALPAR is outperforming its competitive set in profitability, growth, and valuation metrics.

What is WALPAR's market capitalization and what category does it fall into?

WALPAR has a market capitalization of ₹38 crores, making it a Small-cap stock. Small-cap stocks offer high growth potential but with higher volatility and risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for WALPAR?

Key ratios for WALPAR: ROE 15.09% (Excellent), ROCE 16.08%, P/E 16.17x, Debt-to-Equity 0.47, Interest Coverage 14.38x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is WALPAR stock and what is its beta?

WALPAR has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for WALPAR?

WALPAR has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹115.10, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in WALPAR?

Key risks for WALPAR include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.47), and operational challenges. The stock has a Fundamental Score of 38.4/100, indicating higher risk requiring thorough due diligence. Sector-specific risks in Pharmaceuticals & Biotechnology include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is WALPAR's operating profit margin and how has it trended?

WALPAR has a 5-year average Operating Profit Margin (OPM) of 7.63%, which suggests room for improvement in operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is WALPAR's quarterly performance in terms of sales and profit growth?

WALPAR's recent quarterly performance shows YoY Sales Growth of 25.05% and YoY Profit Growth of -11.86%. This shows decent growth momentum in the business. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in WALPAR?

WALPAR has FII holding of 0.00% and DII holding of 0.00%, totaling 0.00% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.